Swiss All Share Index
15.591,90
PKT
-150,35
PKT
-0,96
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.01.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 12.01.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 12.01.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.01.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 11.01.21 | Holcim Hold | Jefferies & Company Inc. | |
| 08.01.21 | Holcim buy | UBS AG | |
| 08.01.21 | UBS Neutral | UBS AG | |
| 08.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 08.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 08.01.21 | Novartis overweight | Morgan Stanley | |
| 08.01.21 | Roche Equal-Weight | Morgan Stanley | |
| 08.01.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 08.01.21 | Holcim Outperform | Credit Suisse Group | |
| 07.01.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 07.01.21 | Holcim Hold | Jefferies & Company Inc. | |
| 07.01.21 | Nestlé Hold | Jefferies & Company Inc. | |
| 07.01.21 | Roche Neutral | Credit Suisse Group | |
| 07.01.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 07.01.21 | UBS Neutral | UBS AG | |
| 07.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 06.01.21 | Holcim buy | UBS AG | |
| 06.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 06.01.21 | Swiss Re buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 06.01.21 | Swiss Re Hold | Deutsche Bank AG | |
| 06.01.21 | Zurich Insurance Hold | Deutsche Bank AG | |
| 06.01.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 06.01.21 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 06.01.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 05.01.21 | Holcim buy | UBS AG | |
| 05.01.21 | Holcim Hold | Jefferies & Company Inc. | |
| 05.01.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 04.01.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.01.21 | Roche Outperform | Bernstein Research | |
| 04.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.12.20 | Roche overweight | JP Morgan Chase & Co. | |
| 21.12.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 18.12.20 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group |